Phase II trial of imatinib (Gleevec®) in patients with metastatic renal cell carcinoma

Jacqueline Vuky, Christina Isacson, Mehran Fotoohi, Jason Dela Cruz, Henry Otero, Vincent Picozzi, Thomas Malpass, David Aboulafia, Andrew Jacobs

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of imatinib (Gleevec®) in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences